Terminal-phosphate-labeled nucleotides and methods of use
Details for Australian Patent Application No. 2002324825 (hide)
International Classifications
Event Publications
16 January 2003 Complete Application Filed
Priority application(s): 60/315,798 29.08.01 US; 10/113,030 01.04.02 US
5 June 2003 Application Open to Public Inspection
Published as AU-B-2002324825
10 August 2006 Change of Name(s) of Applicant(s), Section 104
Amersham Biosciences Corp The name of the applicant has been changed to GE Healthcare Bio-Sciences Corp.
1 November 2007 Application Accepted
Published as AU-B-2002324825
28 February 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002324826-Single nucleotide amplification and detection by polymerase
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser